These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3036328)

  • 21. Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases.
    Okuda K; Kubo Y; Okazaki N; Arishima T; Hashimoto M
    Cancer; 1977 Jan; 39(1):232-46. PubMed ID: 64293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.
    Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M
    Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood group antigens in the intrahepatic biliary tree. I. Distribution in the normal liver.
    Okada Y; Jinno K; Moriwaki S; Shimoe T; Tsuji T; Murakami M; Thurin J; Koprowski H
    J Hepatol; 1988 Feb; 6(1):63-70. PubMed ID: 3279107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of combined ABH and Lewis glycosphingolipids in sera of H-deficient donors.
    Bernoco M; Danilovs J; Terasaki PI; Cartron JP; Mollicone R; Le Pendu J; Oriol R
    Vox Sang; 1985; 49(1):58-66. PubMed ID: 2409675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined hepatocellular-cholangiocarcinoma with variable sarcomatous transformation.
    Nakajima T; Kubosawa H; Kondo Y; Konno A; Iwama S
    Am J Clin Pathol; 1988 Sep; 90(3):309-12. PubMed ID: 2458034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined hepatocellular-cholangiocarcinoma associated with dermatomyositis.
    Horie Y; Yamada M; Nakai K; Kawasaki H; Hirayama C; Matsui K; Kambe N; Shimao S
    J Gastroenterol Hepatol; 1989; 4(1):101-4. PubMed ID: 2562338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of ABH blood group antigens, Ulex europaeus agglutinin I, and type IV collagen in the sinusoids of hepatocellular carcinoma.
    Terada T; Nakanuma Y
    Arch Pathol Lab Med; 1991 Jan; 115(1):50-5. PubMed ID: 1846286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A distinctive antigen present in liver carcinomas induced by 3'-methyl-p-dimethylaminoazobenzene.
    Carruthers C; Baumler A; Neilson A
    Oncology; 1977; 34(2):47-51. PubMed ID: 70767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistologic expression of blood-group antigens in normal human gastrointestinal tract and colonic carcinoma.
    Cordon-Cardo C; Lloyd KO; Sakamoto J; McGroarty ME; Old LJ; Melamed MR
    Int J Cancer; 1986 May; 37(5):667-76. PubMed ID: 3516890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of sialyl-Tn, Tn and T antigens in primary liver cancer.
    Sasaki M; Yamato T; Nakanuma Y
    Pathol Int; 1999 Apr; 49(4):325-31. PubMed ID: 10365852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelial membrane antigen expression in cholangiocarcinoma. An useful immunohistochemical tool for differential diagnosis with hepatocarcinoma.
    Bonetti F; Chilosi M; Pisa R; Novelli P; Zamboni G; Menestrina F
    Virchows Arch A Pathol Anat Histopathol; 1983; 401(3):307-13. PubMed ID: 6314640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of sialylated Lewis(x) antigen in chronic and neoplastic liver diseases.
    Jagirdar J; Thung SN; Shah KD; Nudelman E; Singhal A; Paronetto F
    Arch Pathol Lab Med; 1992 Jun; 116(6):643-8. PubMed ID: 1352099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood group-related antigens in human kidney: modulation of Lewis determinants in renal cell carcinoma.
    Cordon-Cardo C; Reuter VE; Finstad CL; Sheinfeld J; Lloyd KO; Fair WR; Melamed MR
    Cancer Res; 1989 Jan; 49(1):212-8. PubMed ID: 2461798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The use of immunoenzyme analysis for determining ABH antigens in traces of saliva and sperm].
    Deriugina EI; Savel'ev IuI; Nosyrev AE; Lapenkov MI; Nikolaeva TL
    Sud Med Ekspert; 1992; 35(2):23-6. PubMed ID: 1440735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of sialyl Lewis(x) in hepatocellular carcinoma.
    Tori A; Harada A; Nakao A; Nonami T; Ito M; Takagi H
    Hepatogastroenterology; 1995; 42(6):939-43. PubMed ID: 8847049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [2 cases of hepatocholangioma].
    Marciandi C; Raschi P
    Clin Ter; 1975 Jun; 73(5):475-81. PubMed ID: 49236
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
    Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
    Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in the expression of sialyl-Lewisx, a hepatic necroinflammation-associated carbohydrate neoantigen, in human hepatocellular carcinomas.
    Okada Y; Jin-no K; Ikeda H; Sakai N; Sotozono M; Yonei T; Nakanishi S; Moriwaki S; Tsuji T
    Cancer; 1994 Apr; 73(7):1811-6. PubMed ID: 7907941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma.
    Collier JD; Guo K; Mathew J; May FE; Bennett MK; Corbett IP; Bassendine MF; Burt AD
    J Hepatol; 1992 Mar; 14(2-3):377-80. PubMed ID: 1380026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of HLA-DR in intrahepatic cholangiocarcinoma.
    Torii A; Harada A; Nakao A; Nonami T; Nakayama A; Ito M; Takagi H
    Cancer; 1992 Sep; 70(5):1057-61. PubMed ID: 1325267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.